The conversion of $988k debt into freely tradable shares at a micro-cap company with a $2M market cap will likely create heavy selling pressure. Monitor for the actual delivery date of shares (by May 11, 2026) and subsequent trading volume. The investor presentation may contain forward-looking statements, but the core event is dilutive and bearish.
Price Chart
Executive Summary
Glucotrack entered into an Exchange Agreement with an investor to partition a $988,000 promissory note from an existing $3.6M note and exchange it for 1,300,000 shares of common stock, issued free of restrictive legends under Section 3(a)(9). The company also released an updated investor presentation. This debt-to-equity conversion is dilutive to existing shareholders and signals ongoing cash constraints, given the company's $2M market cap.
Key Facts
- Partitioned a $988,000 promissory note from an existing $3.6M note and exchanged it for 1,300,000 shares of common stock.
- Exchange shares are to be issued free of restrictive legends under Rule 144, allowing immediate resale.
- The exchange is subject to a 19.9% beneficial ownership limitation, potentially requiring multiple tranches.
- Company released an updated investor presentation on April 30, 2026.
- Market cap is approximately $2M, making the 1.3M share issuance highly dilutive.
Financial Impact
Dilution of approximately 1,300,000 shares against a $2M market cap, representing a significant percentage of outstanding shares. The $988,000 note is being converted at an implied price of ~$0.76 per share.
Risk Factors
- Immediate dilution of approximately 1.3M shares, significant relative to current market cap.
- Freely tradable shares (no restrictive legend) could lead to rapid selling by the investor.
- Potential for additional tranches if beneficial ownership limit is reached, extending dilution.
- Underlying $3.6M note still outstanding, indicating ongoing debt burden.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-020747 |
| Exhibit: ex10-1.htm | 0001493152-26-020747 |
| Document: 0001493152-26-020747-index-headers.html | 0001493152-26-020747 |
| Document: 0001493152-26-020747-index.html | 0001493152-26-020747 |
| Document: 0001493152-26-020747.txt | 0001493152-26-020747 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.4032 | awaiting T+60 | — | $1.61 (−299.31%) |
Oct 19, 2026 7d ago | 8-K | $0.6511 | awaiting T+60 | — | $1.61 (+147.27%) |
Oct 13, 2026 13d ago | S-1/A | $0.8873 | awaiting T+60 | — | $1.61 (−81.45%) |
Oct 13, 2026 13d ago | 425 | $0.8873 | awaiting T+60 | — | $1.61 (+81.45%) |
Sep 28, 2026 28d ago | 8-K | $1.74 | awaiting T+60 | — | $1.61 (−7.47%) |
Sep 24, 2026 4w ago | 424B5 | $1.82 | awaiting T+60 | — | $1.61 (+11.54%) |
Sep 24, 2026 4w ago | 8-K | $1.82 | awaiting T+60 | — | $1.61 (+11.54%) |
Sep 23, 2026 4w ago | 425 | $2.03 | awaiting T+60 | — | $1.61 (−20.69%) |
Sep 23, 2026 4w ago | 8-K | $2.03 | awaiting T+60 | — | $1.61 (−20.69%) |
Sep 18, 2026 5w ago | 8-K | $2.30 | awaiting T+60 | — | $1.61 (−30.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers